ArticleTherapeutic advances in chronic disease2021

EZH2 is involved in psoriasis progression by impairing miR-125a-5p inhibition of SFMBT1 and leading to inhibition of the TGFβ/SMAD pathway.

Shengming Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.